SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

More documents

Recommendations

Info

P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 McCafferty-Grad, J, Bahlis, NJ, Krett, N, Reis, I, Lee, KP, and Boise, LH. Arsenic trioxide utilizes caspase dependent and caspase independent death pathways in myeloma cells. Molecular Cancer Therapeutics 2:1155-64, 2003. Hernandez, A, Lindner, I, Blomberg, BB, Hussini, S, Burger, M, Mathew, JM, Carreno, M, Garcia-Morales, R, Fuller, L, Jin, Y, Rosen, A, Lee, KP, Miller, J, and Esquenazi, V. Suppression of allogeneic T cell proliferation through blocking of NF-κB in the differentiation process of human dendritic cells. Human Immunology 64:S128, 2003. Levis, S, Quandt, SA, Thompson, D, Scott, J, Schneider, DL, Ross, PD, Black, D, Suryawanshi, S, Hochberg, M, and Yates, J. Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial. Journal of the American Geriatric Society 50:409-15, 2002. Bohlman, MC, Morzunov, SP, Meissner, J, Taylor, MB, Ishibashi, K, Rowe, J, Levis, S, Enria, D, and St Jeor, SC. Analysis of hantavirus genetic diversity in Argentina: S segment-derived phylogeny. Journal of Virology 76:3765-73, 2002. Seijo, A, Pini, N, Levis, S, Coto, H, Deodato, B, Cernigoi, B, de Bassadoni, D, and Enria, D. Medicina (Buenos Aires) 63:193-96, 2003. Hernandez-Cassis, C, Vogel, CK, Hernandez, TP, Econs, MJ, Iglesias, M, Iglesias, A, Levis, S, Roos, BA, Howard, GA, and Gamarra, AI. Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity. Journal of Clinical Endocrinology and Metabolism 88:2650-55, 2003. Jiang, Z, Adams, GB, Hanash, AM, Scadden, DT, and Levy, RB. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation 8:588-96, 2002. Chill, JH, Nivasch, R, Levy, RB, Albeck, S, Schreiber, G, and Anglister, J. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening. Biochemistry 41:3575-85, 2002. Levy, RB and Aoki, C. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. Journal of Neuroscience 22:5001-15, 2002. Yu, A, Zhou, J, Marten, N, Bergmann, CC, Mammolenti, M, Levy, RB, and Malek, TR. Efficient induction of primary and secondary T celldependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. Journal of Immunology 170:236-42, 2003. Calautti, E, Grossi, M, Mammucari, C, Aoyama, Y, Pirro, M, Ono, Y, Li, J, and Dotto, GP. Fyn tyrosine kinase is a downstream mediator of Rho/ PRK2 function in keratinocyte cell-cell adhesion. Journal of Cell Biology 156:137-48, 2002. Li, J, Zhang, YP, and Kirsner, RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microscopy Research and Technique 60:107-14, 2003. Li, J, Tzu, J, Chen, Y, Zhang, YP, Nguyen, NT, Gao, J, Bradley, M, Keene, DR, Oro, AE, Miner, JH, and Marinkovich, MP. Laminin-10 is crucial for hair morphogenesis. EMBO Journal 22(10):2400-10, 2003. Vincel, V, Knowles, J, Li, J, and Nassiri, M. Expression of p63 mRNA isoforms in normal human tissue. Anticancer Research, 23:3945-48, 2003. Zhou, J, Zhang, J, Lichtenheld, MG, and Meadows, GG. A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling. Journal of Immunology 169:1319- 25, 2002. UM/Sylvester Comprehensive Cancer Center Scientific Report 2004 171
P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Lu, Q, Wu, A, Ray, D, Deng, C, Attwood, J, Hanash, S, Pipkin, M, Lichtenheld, MG, and Richardson, B. DNA methylation and chromatin structure regulate T cell perforin gene expression. Journal of Immunology 170:5124-32, 2003. Beaupre, D, Grad, J, Bahlis, N, Boise, L, and Lichtenheld, MG. Farnesyl transferase inhibitors sensitize to death receptor signals and induce apoptosis of multiple myeloma cells. Leukemia & Lymphoma 44:2123-34, 2003. Lipshultz, SE, Lipsitz, SR, Sallan, SE, Simbre, VC 2nd, Shaikh, SL, Mone, SM, Gelber, RD, and Colan, SD. Long-term enalapril therapy for left ventricular dysfunction in doxorubicintreated survivors of childhood cancer. Journal of Clinical Oncology 20:4517-22, 2002. Harmon, WG, Dadlani, GH, Fisher, SD, and Lipshultz, SE. Myocardial and pericardial disease in HIV. Current Treatment Options in Cardiovascular Medicine 4:497-509, 2002. Lipshultz, SE, Giantris, AL, Lipsitz, SR, Kimball, Dalton, V, Asselin, BL, Barr, RD, Clavell, LA, Hurwitz, CA, Moghrabi, A, Samson, Y, Schorin, MA, Gelber, RD, Sallan, SE, and Colan, SD. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 acute lymphoblastic leukemia protocol. Journal of Clinical Oncology 20:1677-82, 2002. Zareba, KM and Lipshultz, SE . Cardiovascular complications in patients with HIV infection. Current Infectious Disease Reports 5:513-20, 2003. Constine, LS, Hinkle, AS, French, CA, Kozlowski, AM, Proukou, C, Lipsitz, SR, Miller, TL, Vermilion, RP, Rifai, N, and Lipshultz, SE. Radiation-associated risk factors for premature cardiovascular disease in childhood cancer survivors include accelerated atherosclerosis. International Journal of Radiation Oncology Biology Physics 57(2 Supplement):S199-200, 2003. Adams, MJ, Lipshultz, SE, Schwartz, C, Fajardo, LF, Coen, V, and Constine, LS. Radiation-associated cardiovascular disease: manifestations and management. Seminars in Radiation Oncology 13:346-56, 2003. Lipshultz, SE, Fisher, SD, Lai, WW, and Miller, TL. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 17 Supplement 1:S96-122, 2003. Fisher, SD, Bowles, NE, Towbin, JA, and Lipshultz, SE. Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes. AIDS 17 Supplement 1:S29-35, 2003. Lipshultz, SE, Somers, MJ, Lipsitz, SR, Colan, SD, Jabs, K, and Rifai, N. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics 112:79-86, 2003. Al-Attar, I, Orav, EJ, Exil, V, Vlach, SA, and Lipshultz, SE. Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome. Journal of the American College of Cardiology 41(9):1598-605, 2003. Benun, J, Fisher, SD, Orav, EJ, Schwartz, ML, Exil, V, Messere, C, and Lipshultz, SE . Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center. American Heart Journal 145:424-9, 2003. Dadlani, GH, Harmon, WG, Simbre, II VC, Tisma-Dupanovic, S, and Lipshultz, SE . Cardiomyocyte injury to transplant: pediatric management. Current Opinion in Cardiology 18:91-7 (Review), 2003. Adams, MJ, Hardenbergh, PH, Constine, LS, and Lipshultz, SE . Radiation-associated cardiovascular disease. Critical Reviews in Oncology/ Hematology 45:55-75 (Review), 2003. Saika, S, Ohnishi, Y, Ooshima, A, Liu, CY, and Kao, WW. Epithelial repair roles of extracellular matrix. Cornea 21 (supplement.): S23-S29, 2002. 172 UM/Sylvester Comprehensive Cancer Center Scientific Report 2004
Page 1 and 2:
S C I E N T I F I C R E P O R T 2 0
Page 3 and 4:
I N T R O D U C T I O N A N D P R O
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
L E A D E R S H I P MULTIDISCIPLINA
Page 13 and 14:
L E A D E R S H I P EXTERNAL ADVISO
Page 15 and 16:
C A N C E R P R E V E N T I O N A N
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
C L I N I C A L O N C O L O G Y R E
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
T U M O R C E L L B I O L O G Y P R
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
T U M O R I M M U N O L O G Y P R O
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134: T U M O R I M M U N O L O G Y P R O
Page 143 and 144: V I R A L O N C O L O G Y P R O G R
Page 157 and 158: S H A R E D R E S O U R C E S 3) La
Page 159 and 160: S H A R E D R E S O U R C E S C E L
Page 161 and 162: S H A R E D R E S O U R C E S D N A
Page 163 and 164: S H A R E D R E S O U R C E S G E N
Page 165 and 166: S H A R E D R E S O U R C E S I N F
Page 167 and 168: S H A R E D R E S O U R C E S P O P
Page 169 and 170: P U B L I C A T I O N S 2 0 0 2 - 2
Page 183: P U B L I C A T I O N S 2 0 0 2 - 2
Page 205 and 206: G L O S S A R Y IFN—interferon IL
show all

SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?